Ekso Bionics (EKSO) Projected to Post Quarterly Earnings on Monday

Ekso Bionics (NASDAQ:EKSO) will likely be announcing its earnings results after the market closes on Monday, March 3rd. Analysts expect the company to announce earnings of ($0.07) per share and revenue of $5.05 million for the quarter. Investors interested in listening to the company’s conference call can do so using this link.

Ekso Bionics Stock Up 1.6 %

Shares of NASDAQ:EKSO opened at $0.52 on Friday. Ekso Bionics has a 52-week low of $0.47 and a 52-week high of $2.16. The stock has a market cap of $11.54 million, a P/E ratio of -0.81 and a beta of 1.46. The business’s 50 day moving average is $0.62 and its 200 day moving average is $0.83. The company has a quick ratio of 2.14, a current ratio of 2.81 and a debt-to-equity ratio of 0.28.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on EKSO shares. HC Wainwright reissued a “buy” rating and issued a $9.00 price objective on shares of Ekso Bionics in a research note on Tuesday, January 14th. StockNews.com started coverage on Ekso Bionics in a research note on Sunday, February 23rd. They issued a “hold” rating on the stock.

Ekso Bionics Company Profile

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets.